首页> 外文期刊>Cancer letters >Essential role of Notch4/STAT3 signaling in epithelial-mesenchymal transition of tamoxifen-resistant human breast cancer
【24h】

Essential role of Notch4/STAT3 signaling in epithelial-mesenchymal transition of tamoxifen-resistant human breast cancer

机译:Notch4 / Stat3信号传导在西氧基抗性人乳腺癌的上皮 - 间充质转变中的基本作用

获取原文
获取原文并翻译 | 示例
           

摘要

We previously demonstrated that tamoxifen (TAM)-resistant human breast cancer (TAMR-MCF-7) cells showed increased expression of mesenchymal marker proteins compared to the parent MCF-7 cells. Notch is functionally important in the promotion of epithelial mesenchymal transition (EMT) during both development and tumor progression. Notchl and Notch4 have been reported as prognostic markers in human breast cancer. Here, we indicated that Notch4, but not Notchl, plays a critical role in the regulation of EMT signaling in TAMR-MCF-7 cells. Notch4 suppression by either Notch inhibitors or Notch4 siRNA attenuated EMT signaling. Tyrosine-phosphorylated STAT3 protein is known as a crucial signaling molecule in the regulation of tumorigenesis and metastasis. We found that TAMR-MCF-7 cells exhibited constitutive STAT3 phosphorylation, and Notch inhibition reduced the level of activated STAT3 in TAMR-MCF-7 cells. An intrasplenic injection model of liver metastases was performed using TAMRMCF-7 cells. Mice injected with N-[N-(3,5-Difluorophenacety1)-L-alanyl]-S-phenylglycine t-butyl ester (DAPT, 10 mg/kg) formed smaller splenic tumors and showed a reduced micrometastatic tumor burden in their livers compared with the control group treated with vehicle. To conclude, Notch4 could be a potential target to prevent metastasis in TAM -resistant breast cancer. (C) 2017 Elsevier B.V. All rights reserved.
机译:我们之前已经证明,与亲本MCF-7细胞相比,耐三苯氧胺(TAM)的人乳腺癌(TAMR-MCF-7)细胞的间充质标记蛋白表达增加。Notch在促进上皮-间充质转化(EMT)过程中起着重要的作用。Notchl和Notch4已被报道为人类乳腺癌的预后标志物。在这里,我们指出Notch4,而不是Notchl,在TAMR-MCF-7细胞的EMT信号调节中起关键作用。Notch抑制剂或Notch4 siRNA对Notch4的抑制减弱了EMT信号。酪氨酸磷酸化STAT3蛋白是调节肿瘤发生和转移的关键信号分子。我们发现TAMR-MCF-7细胞表现出组成性STAT3磷酸化,Notch抑制降低了TAMR-MCF-7细胞中激活的STAT3水平。采用TAMRMCF-7细胞建立肝转移瘤脾内注射模型。与溶媒治疗的对照组相比,注射N-[N-(3,5-二氟苯基乙酰基)-L-丙氨酰]-S-苯甘氨酸叔丁酯(DAPT,10 mg/kg)的小鼠形成较小的脾脏肿瘤,并显示其肝脏中的微转移肿瘤负担减少。总之,Notch4可能是预防TAM耐药乳腺癌转移的潜在靶点。(C) 2017爱思唯尔B.V.版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号